14 “I just can’t afford it.” DMT: Your doctor is very likely to know of financial assistance programs for the DMTs, or organizations (such as MS Focus) that can help you. If you don’t qualify for assistance, your doctor may be able to switch you to another DMT that will have similar benefits, or suggest other options. OTHER: Many people don’t realize that pharmaceutical companies have copay assistance program for medications other than DMTs. Contact the company and see if assistance is available. If not, be open with your doctor about your financial constraints. There may be an alternate medication you could try that costs less. At best, not taking your medication consistently and according to doctor’s instructions means you aren’t getting the full benefit of treatment. At worst, skipping or stopping your medication could be dangerous. Make it part of your self-care to address any concerns you have about your medications, come to an agreement with your doctor about your treatment plan, and stick to it carefully and confidently. Learn More Disease-modifying Drugs for MS: Everything you need to know This MS Focus fact sheet provides you with a quick overview of all the approved DMTs currently being prescribed to help people with MS. Complementary and Alternative Medicine for People with Multiple Sclerosis This easy-to-read booklet from MS Focus explores the diverse and unique therapies that fall outside the scope of conventional medical treatment. This booklet offers unbiased information on therapies such as acupuncture, reflexology, biofeedback, and meditation. Emergency Assistance Grant This MS Focus program provides full or partial financial assistance for FDA- approved MS medication copays. Funds are limited and restrictions apply. MS Coalition, www.ms-coalition.org Through a collaborative national network of independent MS organizations, the coalition seeks to improve the quality of life for those affected by MS through cooperation and by providing greater leverage in collaborative and effective use of resources.